The New York Times | Our Drug Supply Is Sick. How Can We Fix It?
In The New York Times article, “Our Drug Supply Is Sick. How Can We Fix It?”, journalist Farah Stockmanhighlights the founding of Valisure and its role in tackling quality issues in the generic drug supply.
The article shares that Adam Clark-Joseph, at the time an assistant professor at the University of Illinois Urbana-Champaign, co-founded Valisure after personally experiencing a medication that appeared ineffective. Now, Valisure chemically tests every batch of medication it dispenses and rejects about 10 percent due to impurities or inaccurate dosages.
When testing generics of Lisinopril, a common blood pressure drug, Valisure found that some overseas manufacturers matched brand-name standards, while others showed significant dosage inconsistencies.
“If somebody taking blood pressure medication gets stuff that doesn’t work, and they die of a stroke,” Clark-Joseph asked, “are you going to blame the drugs?”
Read the full article via The New York Times here.
